Introduction {#section4-2050313X17723549}
============

Identifying neurogenetic syndromes in patients who display static motor disorders resembling cerebral palsy, intellectual disability and seizures of undetermined etiology is challenging. A Swedish population-based study indicated that an estimated 40% of cerebral palsy cases without a specific etiologic diagnosis were of genetic origin.^[@bibr1-2050313X17723549]^ Molecular genetic testing has facilitated diagnosis of neurogenetic disorders with phenotypes fulfilling criteria for cerebral palsy including the necessary criterion of absence of clinical or neuroradiological regression over time.^[@bibr2-2050313X17723549]^ This testing is increasingly used in the assessment of atypical cerebral palsy cases, where brain magnetic resonance imaging (MRI) images are normal and in the ataxic and hypotonic subgroups. De novo point mutations were recently shown in ataxic cerebral palsy, and it has been suggested that these findings could be relevant to other subtypes of cerebral palsy.^[@bibr3-2050313X17723549]^

Epilepsy, ataxia, sensorineural deafness, tubulopathy (EAST) syndrome, characterized by ataxia, developmental delay and epileptic seizures, in association with renal tubulopathy, sensorineural deafness and hypokalemic, hypomagnesemic metabolic alkalosis, is a relevant example for this discussion. This syndrome links to autosomal recessive mutations in *KCNJ10* (potassium channel, inwardly rectifying subfamily J, member 10), which encodes the Kir4.1 potassium channel.^[@bibr4-2050313X17723549],[@bibr5-2050313X17723549]^ *KCNJ10* is expressed in the renal distal convoluted tubule, cochlear stria vascularis, brain glial cells and other tissues.

*KCNJ10* mutations have been described in five children as EAST syndrome^[@bibr6-2050313X17723549]^ and as seizures, sensorineural deafness, ataxia, mental retardation and electrolyte imbalance (SeSAME) syndrome in five other children,^[@bibr7-2050313X17723549]^ in essence referring to the same clinical entity. Most of these children came from consanguineous families of non-European origin. Although such diagnosis is likely to be very infrequent, it is important to recognize this syndrome in order to assure symptomatic management and inform the families of its static course.^[@bibr8-2050313X17723549]^

The aim of this article is to present a case report of a European male of non-consanguineous origin, with mutation of the *KCNJ10* and the features of EAST/SeSAME syndrome in comparison with the previously reported patients. The importance of identifying cerebral palsy imitators in those patients who display static motor disorders of undetermined etiology is stressed.

Case report {#section5-2050313X17723549}
===========

A 14-year-old Greek male, born to healthy non-consanguineous parents, at term and without perinatal complications, was evaluated for uncontrolled epilepsy. He displayed generalized motor seizures at 3.5 months of age, eventually controlled by anticonvulsants. He showed developmental delay with head control at 4.5 months and ambulation at 19 months with a broad-based unsteady gait. He was diagnosed with ataxic cerebral palsy. In addition, he displayed a delay in speech and generalized learning difficulties at school. Tubulopathy was identified at the age of 8 years. Bartter syndrome was erroneously diagnosed at first. The patient received treatment with potassium gluconate, magnesium, spironolactone and indomethacin. At the same age, sensorineural deafness was detected and a hearing aid was used. At the start of his teenage years, this young man had infrequent secondarily generalized focal motor seizures unresponsive to several medication changes. At 14 years of age, he was a pleasant, cooperative teenager with mild intellectual disability and normal cranial nerve examination (II--XII), normal muscle strength in the upper and lower extremities, mild spastic hypertonia in the lower limbs, increased deep tendon reflexes and bilateral Babinski signs. There was mildly decreased superficial sensation in the lower extremities and no disturbance of position sensation or vibration. Romberg sign was absent. His gait was broad based and slow and he was unable to walk in tandem. Examination for cerebellar signs revealed the absence of tremor and dysmetria, while rapid alternating movements were slow and uncoordinated, resulting in dysdiadochokinesis.

Wakefulness and sleep electroencephalogram (EEG) showed slow background rhythms and no epileptiform activity. Brain computed tomography (CT) and MRI were normal. Nerve conduction studies revealed mild abnormalities on two occasions without important differences between the two tests. The motor conduction velocities on the second measurement were 41.3 m/s for the right median nerve, 38.2 m/s for the right peroneal nerve and 40.8 m/s for the left peroneal nerve. The sensory conduction velocities were 38.6 m/s for the right median nerve, 42.9 m/s for the right ulnar nerve and 42.3 m/s for the right sural nerve. There were no other abnormalities in these electrophysiological studies. Laboratory tests showed normal serum vitamin E, B12, folic acid and plasma very-long-chain fatty acid (VLCFA).

The patient's epilepsy was fully controlled with topiramate and carbamazepine. At F/U, the ataxia remained stable, as was the spasticity, with independent home ambulation and need for support in the community. Episodic weakness appeared on many occasions, without evidence of electrolyte disturbance or clinically overt seizures, and this responded to adjustment of the anticonvulsants. Overall status was consistent with a static disorder of movement, with activity limitations, also associated with intellectual disability and epilepsy. Nevertheless, the unremarkable neuroimaging, the renal tubulopathy and sensorineural deafness, led us to obtain consent from the family to search for a neurogenetic syndrome, specifically for *KCNJ10* mutations associated with EAST syndrome. The patient was heterozygous for two *KCNJ10* mutations: a missense mutation (p.R65C) that is already published^[@bibr9-2050313X17723549]^ and a not yet published duplication (p.F119GfsX25) that creates a premature truncation of the protein ([Table 1](#table1-2050313X17723549){ref-type="table"}). Both mutations are likely damaging. The missense mutation p.R65C has been also listed as disease causing in various databases including OMIM (Online Mendelian Inheritance in Man).^[@bibr10-2050313X17723549]^ In addition, prediction software agrees. As for the truncating frameshift mutation p.F119GfsX25, it is noted that truncating mutations in particular when occurring at the beginning of the protein are most likely damaging. Prediction software agrees here too.

###### 

*KCNJ10* mutations identified on the reported patient.

![](10.1177_2050313X17723549-table1)

  Number   Transcript    Exon/intron   Codon   Protein               DNA            Zygosity
  -------- ------------- ------------- ------- --------------------- -------------- --------------
  1        NM_002241.4   2             65      p.R65C (CGC \> TGC)   c.193C \> T    Heterozygous
  2        NM_002241.4   2             119     p.F119GfsX25          c.297_354dup   Heterozygous

Parental testing has not been performed, and therefore, we do not know for certain whether the mutations are in different alleles, but this also seems quite likely as the missense mutation has already been described in a patient not harboring the additional duplication (and that the same mutation occurred twice is not impossible but very unlikely). This patient's static clinical course has been ascertained for the following 10 years.

Discussion {#section6-2050313X17723549}
==========

This European male with *KCNJ10* mutations presented with an early onset, non-progressive disorder of movement and posture of central origin, causing activity limitations, developmental delay and seizures. In the absence of neurometabolic deviations, these symptoms satisfied the criteria for the initial diagnosis of ataxic cerebral palsy,^[@bibr2-2050313X17723549]^ but further findings proved that this was a cerebral palsy imitator. It is likely that similar misdiagnoses occur as a result of genetic testing being generally expensive or unavailable worldwide. Clinicians should therefore be aware that many neurogenetic syndromes exist with a phenotype resembling cerebral palsy and a static course.

This patient presented with the typical characteristics of EAST syndrome together with certain clinical and laboratory features that differ from previously reported patients with the EAST/SeSAME syndrome ([Table 2](#table2-2050313X17723549){ref-type="table"}). Clinical and laboratory heterogeneity in this syndrome has been reported even between family members sharing the same mutation with each other.

###### 

Clinical features of reported patients.

![](10.1177_2050313X17723549-table2)

  Reference                                                    Patient number/sex   Ancestry        Consanguinity               Onset of seizures           Type of seizure         Developmental delay   Sensorineural deafness   Ataxia   Ability to walk independently   Ability to speak   Prematurity   Age at last follow-up (years)
  ----------------------------------------------- ------------ -------------------- --------------- --------------------------- --------------------------- ----------------------- --------------------- ------------------------ -------- ------------------------------- ------------------ ------------- -------------------------------
  Papavasiliou et al.                                          Index case/male      Greece          No                          Infancy---unspecified age   Generalized and focal   Yes                   Yes                      Yes      Yes                             Yes                No            24
  Scholl et al.^[@bibr7-2050313X17723549]^                     444-1/female         Afghanistan     Yes                         Infancy---unspecified age   Generalized             Yes                   Yes                      Yes      No                              No                 N/A           N/A
                                                               632-1/N/A            Canada          No                          Infancy---unspecified age   Generalized             Yes                   Yes                      Yes      N/A                             N/A                N/A           N/A
                                                               632-2/N/A            Canada          No                          Infancy---unspecified age   Generalized             Yes                   Yes                      Yes      N/A                             N/A                N/A           N/A
                                                               404-1/N/A            Turkey          Yes                         Infancy---unspecified age   Generalized             Yes                   Yes                      Yes      N/A                             N/A                N/A           N/A
                                                               327-1/N/A            Great Britain   N/A                         N/A                         Generalized             Yes                   Yes                      Yes      N/A                             N/A                N/A           N/A
  Bockenhauer et al.^[@bibr6-2050313X17723549]^   Family 1     1-1/female           Pakistan        Yes                         Infancy---unspecified age   Generalized             Yes                   Yes                      Yes      Yes                             Speech delay       No            14.9
                                                  1-2/male     Pakistan             Yes             Infancy---unspecified age   Generalized and focal       Yes                     N/A                   Yes                      No       Speech delay                    No                 9.0           
                                                  1-3/female   Pakistan             Yes             Infancy---unspecified age   Generalized                 Yes                     Yes                   Yes                      Yes      Speech delay                    No                 6.4           
                                                  1-4/female   Pakistan             Yes             Infancy---unspecified age   Generalized                 Yes                     Yes                   Yes                      Yes      Speech delay                    No                 4.6           
                                                  Family 2     2-1/male             Arabia          Yes                         Infancy---unspecified age   Generalized             Yes                   Yes                      Yes      No                              Speech delay       No            3.0
  Kara et al.^[@bibr11-2050313X17723549]^                      Male                 N/A             No                          Infancy-unspecified age     Generalized             Yes                   Yes                      Yes      No                              Yes                N/A           N/A
  Scholl et al.^[@bibr12-2050313X17723549]^                    100-3/female         Somalia         N/A                         Infancy---unspecified age   N/A                     Yes                   Yes                      Yes      Yes                             Yes                N/A           N/A
                                                               100-1/female         Somalia         N/A                         Infancy---unspecified age   N/A                     Yes                   No                       Yes      Yes                             Yes                N/A           N/A
                                                               100-2/male           Somalia         N/A                         Infancy---unspecified age   N/A                     Yes                   No                       Yes      Yes                             Yes                No            N/A
                                                               100-7/female         Somalia         N/A                         Infancy---unspecified age   N/A                     N/A                   Yes                      N/A      N/A                             N/A                No            N/A
  Freudenthal et al.^[@bibr9-2050313X17723549]^   Family 1     1-1/male             Algeria         Yes                         Infancy---unspecified age   N/A                     v                     Yes                      Yes      N/A                             N/A                N/A           N/A
  Family 2                                        2-1/male     Afro-Caribbean       No              Infancy---unspecified age   N/A                         Yes                     Yes                   Yes                      N/A      N/A                             N/A                N/A           
                                                  2-2/female   Afro-Caribbean       No              Infancy---unspecified age   N/A                         Yes                     Yes                   Yes                      N/A      N/A                             N/A                N/A           
  Family 3                                        3-1/male     India                Yes             Infancy---unspecified age   N/A                         Yes                     Yes                   Yes                      N/A      N/A                             N/A                N/A           
                                                               3-2/female           India           Yes                         Infancy---unspecified age   N/A                     Yes                   Yes                      Yes      N/A                             N/A                N/A           N/A
                                                  Family 4     4-1/male             Iran            Yes                         Infancy---unspecified age   N/A                     Yes                   Yes                      Yes      N/A                             N/A                N/A           N/A

N/A: not available.

The young man referred to in this report came from non-consanguineous ancestry, contrary to publications that report on patients from consanguineous ancestry. For EAST syndrome, consanguinity was previously reported as follows: four patients from a Pakistani family,^[@bibr6-2050313X17723549]^ one from Arabic parents,^[@bibr6-2050313X17723549]^ one patient from an Algerian family, two siblings from Indian parents and one from Iranian parents.^[@bibr9-2050313X17723549]^ For SeSAME syndrome, consanguineous families were reported from Afghanistan and Turkey.^[@bibr7-2050313X17723549]^ In total, 11 out of the 22 reported patients were of consanguineous origin, 5 were of no consanguineous origin and for the remaining 5, no information was available. European ancestry is also rare among the reported patients.

Most of the reported patients had delayed psychomotor development and gait ataxia, as was the case with our patient. Some children were unable to walk in contrast to our patient who has maintained ambulation, albeit slow and unsteady. The nature of the syndrome's motor disorder has not been clearly demonstrated.^[@bibr8-2050313X17723549]^ In some of the reported cases, there was cerebellar dysfunction, such as intention tremor^[@bibr7-2050313X17723549]^ and dysdiadochokinesis.^[@bibr6-2050313X17723549]^ The latter was present in our patient as well. Spasticity was also observed in our patient, contributing to gait instability. Spasticity was also described in one of the Scholl's patients.^[@bibr12-2050313X17723549]^ The static clinical course of this patient is consistent with previous observations.^[@bibr8-2050313X17723549]^ The majority of the previously reported patients presented with generalized seizures and three had focal seizures. In our patient, both focal and generalized seizures were described. Most of the reported EEGs were unremarkable. Background abnormalities (as observed in the young man that we describe in this case report) and/or epileptiform activity were present in some reports. The clinical and EEG features of our patient point toward a symptomatic focal epilepsy presenting with focal or secondarily generalized seizures of early onset. Seizure onset in infancy has been observed in most literature reports. Nerve conduction velocities in both our patient and in a patient with SeSAME syndrome were reduced, but these were normal in the remaining reported cases.^[@bibr5-2050313X17723549],[@bibr8-2050313X17723549]^ In the case of the patient reported to within this article, no interpretation for the delayed nerve conduction velocities can be offered. However, peripheral nerve dysfunction is not a frequent finding in patients with EAST syndrome.

Renal ultrasound was normal in both our patient and the previously reported cases. Brain MRI was normal in our patient and in several of the reported cases. Nevertheless, MRI abnormalities in the cerebellum, the brainstem and the corpus callosum have been reported previously.^[@bibr7-2050313X17723549],[@bibr8-2050313X17723549],[@bibr11-2050313X17723549],[@bibr12-2050313X17723549]^ It is possible that with higher resolution MRI, abnormalities could be detected in those patients with unremarkable findings. The MRI findings that have been reported so far are subtle and of uncertain clinical significance^[@bibr7-2050313X17723549],[@bibr8-2050313X17723549],[@bibr11-2050313X17723549],[@bibr12-2050313X17723549]^ and do not allow for conclusions as to the type and extent of brain lesions induced by different *KCNJ10* mutations.

Different mutations in *KCNJ10* were identified in patients with EAST/SeSAME syndrome, as well as in our patient who is heterozygous for two different mutations. However, the lack of genetic testing of his parents does not allow for any conclusions to be drawn regarding the origin of these mutations, that is, whether these were de novo or inherited from his parents.

[Table 3](#table3-2050313X17723549){ref-type="table"} shows the autosomal recessive *KCNJ10* mutations, identified in EAST/SeSAME syndrome and the respective references. The available reports describe many different spontaneous pathogenic mutations in *KCNJ10*. Most of these are homozygous,^[@bibr6-2050313X17723549],[@bibr9-2050313X17723549],[@bibr11-2050313X17723549][@bibr12-2050313X17723549]--[@bibr13-2050313X17723549],[@bibr14-2050313X17723549],[@bibr15-2050313X17723549]^ but there are also heterozygous and compound heterozygous mutations.^[@bibr7-2050313X17723549],[@bibr16-2050313X17723549]^ Our patient has the same missense mutation (p.R65C) as patient 1, described in family 1 of Freudenthal et al.'s^[@bibr9-2050313X17723549]^ report; this mutation is heterozygous, while Freudenthal et al.'s patient is homozygous. Clinical description of Freudenthal et al.'s patient is limited, but all the main features of the syndrome are present. In contrast to our patient, Freudenthal et al.'s patient is of consanguineous origin. Abdelhadi et al.^[@bibr15-2050313X17723549]^ report that among the 14 different pathogenic mutations of *KCNJ10* published so far, the missense mutation c.194G\>C, replacing arginine with proline at the position 65 in the protein structure (p.R65P), is the most frequent of all.

###### 

*KCNJ10* gene mutations.

![](10.1177_2050313X17723549-table3)

  Reference                                                  Patient number     Protein             DNA            Zygosity       Type of mutation
  ----------------------------------------------- ---------- ------------------ ------------------- -------------- -------------- ----------------------------
  Papavasiliou et al.                                        Patient 1          p.R65C (CGC\>TGC)   c.193C \> T    Heterozygous   Missense
                                                                                p.F119GfsX25        c.297_354dup                  Frameshift
  Scholl et al.^[@bibr7-2050313X17723549]^                   Patient 444-1      p.T164I             c.491C \> T    Homozygous     Missense
                                                             Patient 632-1      p.A167V             c.500C \> T    Heterozygous   Compound missense
                                                                                p.R297C             c.889C \> T                   
                                                             Patient 632-2      p.A167V             c.500C \> T    Heterozygous   Compound missense
                                                                                p.R297C             c.889C \> T                   
                                                             Patient 404-1      p.C140R             c.418T \> C    Homozygous     Missense
                                                             Patient 327-1      p.R65P              c.194G \> C    Heterozygous   Compound missense/nonsense
                                                                                p.R199X             c.595C \> T                   
  Bockenhauer et al.^[@bibr6-2050313X17723549]^   Family 1   Patient 1-1        p.R65P              c.194G \> C    Homozygous     Missense
                                                             Patient 1-2        p.R65P              c.194G \> C    Homozygous     Missense
                                                             Patient 1-3        p.R65P              c.194G \> C    Homozygous     Missense
                                                             Patient 1-4        p.R65P              c.194G \> C    Homozygous     Missense
                                                  Family 2   Patient 2-1        p.G77R              c.229G \> C    Homozygous     Missense
  Kara et al.^[@bibr11-2050313X17723549]^                    Boy, 8 years old   R204H               N/A            Homozygous     N/A
  Scholl et al.^[@bibr12-2050313X17723549]^                  Patient 100-3      T57I                ACA \> ATA     Homozygous     Missense
                                                             Patient 100-1      T57I                ACA \> ATA     Homozygous     Missense
                                                             Patient 100-2      N/A                 N/A            N/A            N/A
                                                             Patient 100-7      T57I                ACA \> ATA     Homozygous     Missense
  Freudenthal et al.^[@bibr9-2050313X17723549]^   Family 1   Patient 1-1        p.R65C              c.193C \> T    Homozygous     Missense
                                                  Family 2   Patient 2-1        p.F75L              c.225T \> G    Homozygous     Missense
                                                             Patient 2-2        p.F75L              c.225T \> G    Homozygous     Missense
                                                  Family 3   Patient 3-1        c.775delG           p.V259fsX259   Homozygous     Frameshift
                                                             Patient 3-2        c.775delG           p.V259fsX259   Homozygous     Frameshift
                                                  Family 4   Patient 4-1        p.R297C             c.889C \> T    Homozygous     Missense
  Parrock et al.^[@bibr13-2050313X17723549]^                 Patient 1          p.F75C              N/A            Homozygous     N/A
                                                             Patient 2          p.A167V             N/A            Homozygous     N/A
                                                             Patient 3          p.V91fs197X         c.272delT      Homozygous     N/A
                                                             Patient 4          p.A167V             N/A            Homozygous     N/A
  Thompson et al.^[@bibr14-2050313X17723549]^                Patient 2          p.R65P              N/A            Homozygous     Missense
                                                             Patient 3          p.R297C             N/A            Homozygous     N/A
  Reichold et al.^[@bibr16-2050313X17723549]^                Patient 1          p.R65P              c.194G \> C    Heterozygous   N/A
                                                             Patient 2          p.G77R              c.229G \> C    Homozygous     N/A
                                                             Patient 3          p.R175Q             c.524G \> A    Homozygous     N/A
                                                             Patient 4          p.R199X             c.595C \> T    Heterozygous   N/A
  Abdelhadi et al.^[@bibr15-2050313X17723549]^    Family 7   Patient 12         p.R65P              c.194G \> C    Homozygous     Missense

N/A: not available.

In summary, EAST/SeSAME syndrome should be considered in patients with renal tubular disorders in association with developmental delay, ataxia, epilepsy and sensorineural deafness. Neurogenetic syndromes may present as cerebral palsy imitators, and therefore, patients should be genetically investigated if the history and the neuroimaging do not clarify the etiology, in order to ensure appropriate management, prognosis and genetic counseling.
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